Selective T Cell Costimulation Modulator [EPC]
3 drugs in this class with 330,991 total adverse event reports.
3 Drugs
330,991 Total Reports
135,890 Serious Reports
27,036 Death Reports
| # | Drug Name | Generic Name | Reports | Serious | Deaths |
|---|---|---|---|---|---|
| 1 | Abatacept | ABATACEPT | 135,352 | 54,545 | 8,943 |
| 2 | Tocilizumab | TOCILIZUMAB | 111,773 | 46,569 | 11,929 |
| 3 | Golimumab | GOLIMUMAB | 83,866 | 34,776 | 6,164 |